AzTrials
AzTrials

Developmental Dysplasia of the HipNCT05929105

AI-assisted Preoperative Planning Technology for THA for DDH

An observational study of Developmental Dysplasia of the Hip, run by General Hospital of Ningxia Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, the investigators retrospectively collected DDH case data of THA assisted by AI 3D planning and THA assisted by traditional planning. The compliance between preoperative planning and the type of prosthesis used in the operation, the position of the acetabular prosthesis, the correction of LLD and the… Read more about this study

Who is it for?
Any age
Conditions the study is for
Developmental Dysplasia of the Hip
What is being tested?
artificial intelligence (AI)-assisted three-dimensional preoperative planning technology and X-ray film template for 2D planning
Type of treatment
Surgery or procedure
How many people
61 participants
Where
1 siteChina
Study dates
4 Jan 2020to 30 Oct 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with DDH who underwent unilateral primary THA between January 2020 and July 2022 in the orthopaedic department.

Who may be able to join

  • DDH was diagnosed by clinical signs and imaging examination, and a primary THA was planned;
  • the patient had persistent unilateral hip pain, which seriously affected their quality of life;
  • the standard posterolateral approach was used;
  • the contralateral hip was normal or had received THA;
  • the proximal femoral Dorr classification was type A or B;
  • The acetabular classification was Crowe type Ⅰ, Ⅱ, Ⅲ or IV;
  • all patients were treated with the bioartificial hip joint PINNACLE® cup or SUMMIT® stem, developed by Johnson \& Johnson Biological.

Who cannot join

  • preoperative and postoperative imaging examinations did not meet the evaluation criteria (non-standard double-hip anteroposterior film, acetabular angle and LL length could not be accurately measured);
  • severe osteoporosis, tumour or metabolic disease around the affected hip joint;
  • spinal deformity by other causes or a history of lumbar internal fixation;
  • external deformity of the affected hip joint in the lower extremity;
  • neuromuscular insufficiency (with hip abduction weakness and poliomyelitis);
  • severe disease with intolerance to surgery.

Trial locations and contacts

1 site in 1 country.

China1 site
  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, 750001

Other trials in China

About this study

Official title: Short-term Outcome of Artificial Intelligence-assisted Preoperative Three-dimensional Planning of Total Hip Arthroplasty for Developmental Dysplasia of the Hip Compared With Traditional Surgery

In this study, the investigators retrospectively collected DDH case data of THA assisted by AI 3D planning and THA assisted by traditional planning. The compliance between preoperative planning and the type of prosthesis used in the operation, the position of the acetabular prosthesis, the correction of LLD and the postoperative joint function score were analysed to evaluate the short-term effect of AI combined with preoperative 3D planning in THA for DDH.

Being tested
artificial intelligence (AI)-assisted three-dimensional preoperative planning technology, X-ray film template for 2D planning
Medical subject headings
Developmental Dysplasia of the Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • artificial intelligence (AI)-assisted three-dimensional preoperative planning technologyProcedure or surgery

    In the AI planning group, AI was used to assist in the 3D planning to complete the preoperative design. Preoperative planning was performed by two experienced surgeons and without the chief physician to ensure that the results of the preoperative planning did not affect the selection of intraoperative procedures and prosthesis size.

  • X-ray film template for 2D planningOther

    A traditional X-ray film template was used to complete the preoperative design in the traditional planning group. The position and size of the prosthesis, the level of femoral neck osteotomy, the length of the LLs and the restoration of eccentricity were estimated by X-ray. A plastic template provided by the manufacturer was used to take the line of the lower edge of the teardrop on both sides as the horizontal reference line, and the acetabular template was placed at 40 abduction on the inner edge of the teardrop so that the lower edge of the acetabular cup was adjacent to the teardrop. An appropriate type of acetabular component was selected to fill the acetabulum and maintain coverage, and the femoral component that best matched the femoral medullary cavity was chosen. The height of the osteotomy was determined, and the planning model was recorded after the surgeons were happy with the placement and outcome.

Study groups in NCT05929105
Study groupRoleWhat they receive
observation groupNot described
Receives: Procedure: artificial intelligence (AI)-assisted three-dimensional preoperative planning technology
control groupNot described
Receives: Other: X-ray film template for 2D planning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Type of acetabular cup and femoral stem

    Accuracy analysis of planning model and the practical model

    Measured: 31 months

  2. Difference in the length of lower limbs before and after surgery

    Prove the accuracy of the artificial intelligence planning group

    Measured: 31 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2023
  2. Study start4 Jan 2020
  3. Primary completion30 Jul 2022
  4. Study completion30 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05929105
Sponsor's protocol ID
lipeng2023
Status last verified
Jun 2023
First submitted
5 Jun 2023
Last updated
3 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Developmental Dysplasia of the Hip, run by General Hospital of Ningxia Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Type of acetabular cup and femoral stem (time frame: 31 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in